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Chapter I 
Background 
Tbe genus Brucella: 
Brucella is a gram-negative coccohacillus and a facultative intracellular orgamsm. 
Brucella was named after Sir David Bruce who, in 1887, first discovered the organism 
from the spleen of infected British soldiers residing in Malta. The genus Brucella is 
divided according to cultural, metabolic, and antigenic characteristics into six species: B. 
melitensis, B. abortus, B.canis, B. ovis, B. suis, and B. neotomae. Three of the six 
Brucella spedes include several biovars. B. melitensis has biovars 1, 2, and 3, B. abortus 
includes biovars 1,2, 3,4, 5, 6, and 9, and B. suis includes biovars 1, 2,3,4, and 5. The 
major difference among the Brucella species is their host preference. B. melitensis infects 
sheep and goats and it is the most common pathogen causing brucellosis in humans. B. 
abortus primarily infects cattle but it can infect buffaloes, camels, deer, dogs, horses, 
sheep, and man. Different biovars of B. suis infect different animal hosts. Biovars 1 and 3 
infect swine, biovar 2 infects European wild hares, biovar 4 is responsible for infection in 
reindeer and wild caribou, and biovar 5 infects rodents. Except for biovar 2, all B. suis 
biovars can be transmitted to humans. B. canis is responsible for epididymo-orchitis in the 
B.neotomae is only known to infect the desert wood rat [1]. Recently, new 
uncharacterized strains of Brucella were isolated from many marine mammals such as 
seals, porpoises, dolphins, and a minke whale [2]. These strains were identified as 
Brucella by conventional typing tests, but th.eir o~eral1 characteristics, however, are not 
similar to those of any ofllie six known Brucella species. Therefore it was suggested that 
these strains be grouped under a seventh species to be named as "Brucella maris" [2]. 
Meyer and Shaw, in 1920, described some basic characteristics of the genus Brucella. All 
the species in the genus are non-motile and non-sporing occUlTing singly, in pairs, or in 
short chains. They are aerobic and do not grow under strictly anaerobic conditions. Most 
of the strains in the genus are carboxyphilic. Their metabolism is mainly oxidative but 
shows a little fermentative action on carbohydrates in conventional media. Thiamine, 
biotin, and nicotinamide are required, and the growth of many strains is improved by 
calcium pantothenate and meso-erthritol. All the Brucella species are catalase positive, 
usually oxidase positive, reduce nitrates, produce HzS, and do 110t produce indole or 
acetyl-methyl carbinol. They do not utilize citrate and their methyl red reaction is 
negative. The optimum growth temperature for the bacteria in this genus is 37°C and it 
ranges from 20-40 °C. The optimum pH for growth is between 6.6 and 7.4. The species 
and the biovars within each species are differentiated on the basis of specific 
combinations of characteristics. These include phage lysis, CO2 requirement, HzS 
production, serological specificity, tolerance to dyes and oxidative metabolic profiles 
with standard substrates. 
The genus Brucella 1S responsible for a serious infection, causmg abortions in 
animals and a febrile disease known as brucellosis or Malta fever in man. The incubation 
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period of brucellosis is usually one to three weeks, but sometimes may be several months 
[28]. The illness may be mild and self-limiting OT severe. It may have either a sudden or 
insidious onset and is accompanied by continued, intermittent, or irregular fever. The 
symptomatology of brucellosis is like that of many other febrile diseases, but with a 
marked effect on the musculoskeletal system evidenced by generalized aches and pains 
and associated with fatigue, prostration and mental depression [28]. Urogen~tal symptoms 
may dominate the dinical presentation in some patients. The duration of the disease can 
vary from a few weeks to several months and laboratory tests are needed to confirm the 
clinical diagnosis. Brucellosis in humans and animals is increasing in certain parts of the 
world, especially in developing areas of the Mediterranean Region, Middle East, western 
Asia and parts of Africa and Latin America. Brucellosis is transmitted to humans through 
direct contact with infected animals or through the consumption of unpasteurized dairy 
products. Cases in which Brucella was transmitted through inhalation were also reported 
and it is very common in laboratory-acquired infections. Brucellosis is treated by a 
combination of antibiotics for several weeks [28]. 
Brucella genome: 
The study of the Brucella genome started back in late 60s when Hoyer and Mc Cullough 
used DNA homology to discover the relationship among different Brucella strains [3]. 
The first: attempt to map the Brucella genome was done by Altenbern who used chemical 
mutagenesis to induce auxotrophic mutants of B. abortus S19, and then used marker 
fTequency analysis to map certain genes [4]. DNA hybridization assays showed that the 
Brucella strains share over 90% of homology [5]. This fact lead Verger et 311 in 1985 to 
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suggest that the genus Brucella is a monospecific genus with B. melitensis being the main 
species and the other species just being biovars [5]. 
The complete genome sequences of B. suis and B. m.elitensis, and recently B. abortus 
are now available. The genome sequence of B. suis strain 1330, a standard reference 
strain for B. suis biovar 1, was sequenced by the whole genome sequencing method [6]. 
...... 
The genome of B. suis 1330 consists of two circular chromosomes. Chrqmosome I is 
composed of 2,107,792 bp with 2185 ORFs, while chromosome II is composed of 
1,207,381 bp with 1203 ORFs. Chromosome r resembles other bacterial circular 
chromosomes with the origin of replication adjacent to a gene cluster composed of dnaA, 
dnaN, and reeF [7]. Chromosome II, on the other hand, contains a cluster of plasmid-like 
replication genes such as initiation protein RepC and partitioning proteins RepA and RepB 
[7]. Chromosome I encodes the majority of the core metabolic machinery for processes 
such as transcription, translation, and protein synthesis [7). In addition to that, 
chromosome I encodes many phage related proteins due to inserted phage remnants. 
Chromosome II, on the other hand, encodes proteins responsible for membrane transport, 
central intermediary and energy metabolism and regulation [7]. Chromosome II possesses 
genes responsible for cellular processes and plasmid functions primarily because of the 
presence of three clusters of flagellar biosynthesis and secretion genes and the cluster of 
conjugation-associated and plasmid-like replication genes on Chromosome II, 
respectively [7]. Chromosome II also contains essential genes such as the solitary tRNA-
Cys and three aminoacyl-tRNA synthetases. 
When compared, the genomes of B. suis and B.melitensis show a very high level of 
similarity. More than 90% of B. suis and B. melitensis genes share 98-100% identity at 
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the nucleotide level [7]. The more variable genes share less than 950/0 identity and they 
include hypothetical genes, UreE urease component, and probable surface-exposed genes 
such as outer membrane proteins, membrane transporters, a putative invasin, and Shd-like 
adhesion protein [7]. These more variable genes may contribute to the differences in 
pathogenicity and/or host preference between the two species. Whole genome alignments 
revealed 42 B. suis and 32 B. melitensis genes that are completely absent in the other's 
genome. Thirty-three regions of greater than 100 bp unique to either B. suis (22 regions) 
or B. melitensis (11 regions) were identified [7]. The pres.ence of two replicons was 
confmned in all the Brucella species and their biovars with the exception of B. suis 
biovar 3, which has only one replicon of about 3100 kb [8]. At the proteomic level, the 
annotated protein data sets of B. melitensis and B. suis also contain additional differences 
because of frame-shifted or truncated genes and different predictions of hypothetical 
genes [7]. 
Like other Brucella species, B. suis is a member of the alpha-proteobacteria, related 
to other human/animal pathogens such as Bartonella spp. and mOI"e distantly to plant 
pathogens su.ch as Agrobacterium tumefaciens and to plant symbionts such as 
Sinorhizobium meliloti [9]. Complete genome analysis of B. suis showed that the 
predicted B. suis proteins are, in fact, very similar to those of species in the 
rbizobiumlagrobacterium group. [7]. A total of 1902 B. suis ORF's were conserved in all 
tbe three: Mesorhizobium loti, S.meliloti, and A. tumefaciens and 2408 B. suis ORFS were 
conserved in at least one of these three genomes [7]. Like B. suis, M.loti, S.meliloti and 
A. tumefaciens have multiple replicons [7]. B. suis Chromosome I shares regions of gene 
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synteny with Mloti. Chromosome II shares limited regions of gene synteny with Mloti 
and the linear plasmid of A. tumefaciens and the Sym megaplasmid of Smeliloti. 
At the genome level, the Brucella species and biovars are differentiated from each 
other by the restriction patterns of certain genes especially genes coding for outer 
membrane proteins (OMPs). The major porin OMP of 36 KD is encoded in the omp2 
locus, first sequenced in B. abortus. [11]. The locus is composed of two genes omp2a and 
omp2b, separated by 900 bp and oriented in opposite directions. [11]. Only omp2b seems 
to be expressed at least in B. abortus. [11]. The first evidence of polymorphism at the 
omp2 locus between Brucella species was obtained by Fieht et al [12J in 1990. He 
showed that all the Brucella species reference strains have one copy of both omp2a and 
omp2b with the exception of B.ovis which has two copies of omp2a and lacks the omp2b. 
[12]. Recently, it has been shown that a Brucella strain isolated from a marine mammal 
bears two copies of omp2b gene and lacks the omp2a, which is a third type of 
arrangement at the amp2 locus in the genus Brucella. [13]. Specific oligonucleotide 
probes were designed to differentiate the six Brucella strains and their biovars by 
hybridization to peR amplified omp2 fragments [14]. Omp2 locus can also be used to 
differentiate Brucella strains and biovars by analyzing the restriction profile, which is 
unique for each strain with some exceptions. Other omp genes like omp25, omp3], 
omplO, omp16, and omp19 are also used to type Brucella strains and their biovars. 
Virulence: 
The genome analysis of three Brucella specIes confinned the absence of most of the 
genes that code for the classical virulence factors and pathogenic islands common in 
other bacteria. In addition to tha.t, the Brucella genome lacks a complete set of genes such 
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as genes encoding types I and II secretion systems, and part of the type III secretion 
system. Adhesion, invasion, inhibition ofphagolysosomal fusion and granule release, and 
its ability to replicate inside the cell, are essential factors in Brucella virulence. 
Brucella can invade a wide variety of mammalian cells including professional and 
nonpwfessional phagocytes. Ackermann showed that M cells, macrophages, and 
neutrophils ingest Brucella by zipper-like phagocytosis [15]. Opsonized Brucella are 
internalized through complement and Fc receptors in macrophages and monocytes while 
non-opsonized Brucella penetrate by lectin orfibronectin receptors in addition to some 
uncharacterized receptors [16]. It was shown that the trafficking of Brucella inside the 
professional phagocytes depends on the mechanism by which the bacteria were 
internalized into the cell. The opsonized Brucella phagocytized by activated macrophages 
is more prone to be destroyed than the bacteria internalized by other mechanisms [17]. 
Brucella invades the non-professional phagocytes through the recruitment of 
microtubules and actin cytoskeleton. Treating the target cells with Cytochalasin D or 
nocodazole impairs the internalization of Brucella into the cells, indicating the need for 
these elements in the cell invasion process [18]. 
In the first five minutes aft.er invasion, the Bnicella-containing compartments (BCC) 
of both B. abortus and the attenuated strain 19 were found to contain the transferrin 
receptor, the small GTP-binding protein rab5, or the early endosomal antigen (EEAl). 
[19]. The presence of these markers in the Bee indicates an interaction of the Brucella 
with an intracellular compartment related to the early endosomal network. After 10 min. 
of internalizati.on the number of BeCs labeled with either rabS or EEA1 decreases 
significantly and no labeling is detected with these markers after 30 min. [19]. The 
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integrity of the early endosomal system is relevant to the subsequent nomlal trafficking 
of B. abortus in host cell [18]. Neither B. abortus strain 2308 nOr the attenuated strain 19 
interacts with the late endosomal network 30 minutes post-invasion [19]. The BeC is 
transfonned gradually to a muItimembranous compartment Containing the Iysosomal-
associated membrane protein (LAMP) 1, and the endoplasmic reticulum marker sec6 t (3, 
but devoid of the luminal lysosomal hydrolase cathepsin D, indicating that toe B. abortus 
inhibits the fusion of its phagosome with lysosomal compartments [18]. The late BCe 
was identified as an autophagosome. The association of Brucella with the autophagic 
pathway is still a mystery. An interaction between the early endocytic compartments and 
autophagic vacuoles was detected indicating that a physical connection might exist 
between early Bee and autophagosomes [18]. 
About 24 hours postinoculation, B. abortus and the attenuated strain 19 take two 
different ways inside the cell. The strain 19 containing phagosomes retain LAMP-l and 
acquire the lysosomal marker cathepsin D, indicating that the bacteria are delivered. to the 
lysosomes [19]. On the other hand, phagosomes containing the virulent strain 2308 lose 
the LAMP-l marker and never acquire any lysosomal markers [19]. The final Bees, 
however, retain the sec61(3 labeling and acquire other markers of the endoplasmic 
reticulum [19]. These data as well as other experimental data suggest that the virulent 
Brucella transits from autophagosomes to the endoplasmic reticulum of the host cell 
where the actual bacterial multiplication occurs? and that the integrity of the host 
endoplasmic reticulum is essential for Brucella multiplication and survival inside the host 
cell [18]. 
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The benefits that Brucella and other intracellular pathogens acquire through association 
with the host endoplasmic reticulum are stiU unknown. The intracellular trafficking of 
Brucella is almost the same inside the professional and nonprofessional phagocytes 
except that fewer bacteria finally reach their replication niche in the macrophages. 
Certain factors were found essential for the survival of the Brucella inside the target cells. 
Brucella Guter membrane contains certain lipopolysaccharides that protect the bacteria 
from the bactericidal activity of the cationic peptides. Another important factor for 
Brucella virulence is that which inhibits the phagosome-lysosome fusion. This factor is 
not identified yet, but B. abortus extracts containing 5 '-guanosine monophosphate and 
adenine were found to inhibit neutrophil degranulation [18]. 
Hong et al generated a pool of B. abortus mutants by signature tagged mutagenesis 
and identified the genes necessary for establishing chronic infection and those required to 
sustain the infection [20]. Mutants with defects in establishing an infection include those 
with an insertion in the wbkA gene, which encodes mannosyltransferase" a necessary 
enzyme in the O-antigen biosynthesis pathway. Mutants with insertions in either virBl or 
virBIO regions also failed to establish an infection. VirB is an operon composed of twelve 
genes and encodes the type IV secretion system. The operon is induced by phagosome 
acidification in cells after phagocytosis. Type IV secretion system is essential in Brucella 
virulence since it secretes molecules that allow Brucella to pervert the host cell 
endosomal pathways and to create the intracellular compartment in which it can replicate 
[21]. Among mutants that could not sustain a chronic infection are those that have 
insertions in genes involved in metabolic activities. B. abortus with mutations in giuP 
(encoding glucose and galactose transporter), and gilD (the small subunit of glutamate 
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synthase) were defective in sustain.ing a chronic infection, indicating that glucose, 
galactose, or glutamate may serve as carbon and/or :nitrogen SOurce during the growth of 
B. abortus in the target cell [20]. 
Another important factor in Brucella virulence is the (BvrRIBvrS) two component 
\, regulatory system, which is essential in the invasion process. BvrRlBvrS Brucella mutants 
poorly invade target cells, fail to reach the autophagoctyic compartments, and are rapidly 
destroyed in lysosomes[18]. However, the external factors that activate this system as 
well as the downstream factors that are regulated by the BvrRlBvrS system are still to be 
identified. Identifying genes that are essential for Brucella virulence will allow creating 
null mutants that can be used as live attenuated vaccines. 
10 
Figure 1. "Schematic model of the intracellular trafficking of B. abortus in host cellS' 
Virulent B. abortus strain 2308 as well as attenuated strain 19 interact during the first 
minutes after invasion with the early endocytic network of host cells, characterized by tpe 
presence of markers such as rab5 and EEA1. Brucellae are then located in a 
multimembranous autophagosome presenting the molecules LAMP-I and sec61f3. 
During the late stages of infection, attenuated strain 19 is degraded in a mature 
autophagosome after fusion of the bacterial-containing compartment with lysosomes 
(rich in cathepsin D), while virulent strain 2308 proliferates in the endoplasmic reticulum 
of target cells." 
Reference: Pizarro-Cerda J, Moreno E, Gorvel JP. 2000. Invasion and intracellular trafficking of 
Brucella abortus in nonphagocytic cells. Microbes Infect. 2000.2:829-35. 
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Fig. 2. "The typical intracellular growth curves of Brucella suis in macrophages. The 
different types of compartments in which the bacteria might reside during the COUrse of 
infection are symbolized by coloured ovals as follows: blue, subversion of the 
macrophage; green, brucellosome; red, phagosome-lysosome fusion. Rough mutants 
decrease rapidly in number during the first hours and only a few bacteria reach a safe 
replicative niche, enabling initiation of intracellular multiplication. Abbreviations: att, 
attenuated mutant with low-Level replication; Rough, rough mutants; virB, strongly 
attenuated virB mutant that is rapidly eliminated; WT, wild-type." 
Reftrence: Kohler S, Michaux-Charachon S, Porte F, Ramuz M, Liautard JP. 2003. What 15 the 
nature of the replicatIve niche ofa stealthy bug named Bmcella? Trends Microbial. 11:215-9. 
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Brucellosis Vaccines: 
Extensive research has been done to find a vaccme that can limit the econOffilC and 
medical losses ofBruceUosis. 
B. abortus strain 19: 
B. abortus strain 19 was the first vaccme lUsed for Brucellosis. Strain 19 was first 
described in 1930. The strain was isolated in 1923 as a virulent strain from Jersey cow 
milk, and after being kept in the lab at room temperature for over a year, had become 
attenuated [22]. Strain 19 was able to induce protective immunity in cattle, but, however, 
vaccination of pregnant cattle can cause abortion. B. abortus strain 19 can't grow on 
media that contain erythritol. Being a smooth strain (i.e. it contains the LPS with an 0-
chain in its outer membrane) created a technical problem. Antibodies to these outer 
membrane polysaccharides appear in the serum of vaccinated animals. The production of 
these antibodies makes the continued use of the vaccine incompatible with the 
simultaneous application of test and slaughter procedures for the control of Brucellosis. 
B. melitensis Rev.I: 
B. melitensis Rev.] is a live attenuated vaccine derived from a B. melitensis strain that 
became dependent on stTeptomycin for its growth. The strain lost the need for 
streptomycin after further subculture but didn't lose the streptomycin resistance. It 
protects sheep and goats against B. melitensis infection, and rams against infection with 
B.ovis [22]. Rev.1 is a smooth organism; therefore it induces positive serology which 
interferes with the diagnosis. 
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B .abortus strai" 45/20: 
B. abortus strain 45/20 IS a llve attenuated rough strain derived from the smooth B. 
abortus strain 45/0 after 20 passages in guinea pigs. This strain can protect guinea pigs 
and cattle from Brucella infection [22]. It is, however, an unstable strain that can revert to 
a smooth phenotype, therefore it was used as a bacterin incorporated in adjuvants usually 
based on water and oil emulsions. 
B. abortus straillRB51: 
B. abortus strain RB51 is a live attenuated rough B. abortus strain. Strain RB51 is 
attenuated in mice, goats, gumea pIgS, and cattle. It almost has no abortifacient 
characteristics, and it induces the same or better protection than the attenuated strain 19 
[22]. 
Other vaccines: 
Vaccine preparations, which include killed Brucella, were tested. With the exception of 
B. abortus strain 25120, the application of these preparations is not practical. Production 
cost, poor protection, and serological interference are reasons which make using these 
vaccine preparations not feasible [22]. Antigenic fractions extracted from Brucella have 
been used also in a variety of adjuvants, and protection was achieved with some of these 
preparations. Preparations used include whole killed cells, cell envelopes, outer 
membrane proteins, periplasmic proteins, salt extractable proteins, modified Brucella 
proteins, and smooth and rough LPS [22]. 
DNA vaccines: 
The basic principle of DNA vaccines involves tbe introduction of genes encoding protein 
antigens responsible for stimulating a protective immune response. The genes are doned 
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III a plasmid vector that can just replicate in prokaryotes and can replicate and be 
expressed in eukaryotic cells [22]. There are a limited number of studies on Brucella 
DNA vaccines, and most of them were done on small animal models. Brucella DNA 
vaccines which have been tried on mice did not achieve the same level of protection that 
the live attenuated strains did. 
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Chapter II 
CONSTRUCTION OF BRUCELLA Abortus STRAINS REQUIRING AROMATIC 
AMINO ACIDS AND MDTANT IN PGI GENE 
Introduction: 
The aromatic ammo acids phenylalanine, tyrosine, and tryptophan are synthesized in 
prokaryotes, yeasts and filamentous fungi, apicomplexan parasites, and the p)astids of 
plants and algae. As essential amino acids, phenylalanine and tryptophan are required 
ingredients in the diet of animals, who can synthesize tyrosine by hydroxylation of 
phenylalanine. Chorismic acid is a branching point in the aro pathway from which 
separate pathways lead to individual aromatic amino acids, and to para-aminobenzoic 
acid and hence folic acid. Bacteria aro mutants are auxotrophic for the aromatic amino 
acids, para-aminobenzoic acid, and 2,3 dihydroxybenzoic acid. Some of these 
compounds are not available at sufficient levels in the host mammalian cell to sustain 
growth of the aro mutated intracellular bacteria leading to attenuation. In 1981 Hoiseth 
and Stocker showed that Salmonella enterica serovar Typhimirium aroA (EPSP synthase) 
mutant was both attenuated and an excellent live vaccine in the mouse typhoid model 
[23]. Hong et al. defined a Brucella mutant that was auxotrophic for aromatic amino 
acids and at the same time could not establish a chronic infection. The major aim behind 
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[23]. Hong et a1. defmed a Brucella mutant that was auxotrophic for aromatic amino 
acids and at the same time could not establish a chronic infection. The major aim behind 
my research was to construct Brucella mutants that are deficient in aroA and aroBE 
genes, which are involved in the aromatic amino acids pathway. Fig. 3 shows the role of 
these genes in the aromatic amino acid biosynthesis pathway. Another goal of this 
research was to construct pgi Brucella mutant. Pgi codes fOF a phosphoglucoisomerase, 
an enzyme that catalyzes the reaction: fructose-6-phosphate to glucose-6-phosphate. B. 
suis that carries a mutated Pgi gene was found to be attenuated [29]. The importance of 
the Pgi gene for the viability of Brucella is not yet known. However, pgi gene plays an 
important role in glucose llletabolism in Brucella. Brucella metabolizes glucose through 
the pentose phosphate pathway. Since Brucella lacks the enzyme phosphofructokinase, it 
cannot utilize fructose-6-phosphate. The Pgi gene product therefore is important for 
Brucella since it enables the organism to recycle fructose-6-phophate to glucose-6-
phosphate [30]. 
The ultimate goal is to study the survival of these Brucella constructs in macrophage 
cell culture and in animal ITIodel. 
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Chapter III 
Mater~als and Methods 
Bacterial strains, plasmids,. media, and growth conditions: 
Virulent B.abortus strain 2308 was obtained from the Oklahoma Animal Disease 
Diagnostic Laboratory. E.coli strains were obtained from Dr. Richard Essenberg's lab 
stocks and they are listed in Table 1. 
Plasmids were obtained from B.abortus genomic library that was prepared by S. Kay 
Nida and they are listed in Table 2. The media used to grow E.coli and B.abortus are 
listed in Table 3. E. coli strains were routinely cultured at 37°C overnight. Brucella cells 
are grown in a BL3 laboratory at 37°C under an atmosphere containing 5% CO2 for 4 to 6 
days. For E. coli strains, 50 Ilg/ml ampicillin, 30 fJglml kanamycin and 30 Ilglml 
chloramphenicol were added as required, while Brucella strains required 100 Ilglml 
ampicillin, 60 Ilglml kanamycin and 30 f-lg/ml chloramphenicol. 
Preparation and manipulation of DNA 
Plasmid DNA was purified by the QIAprep Spin Miniprep Kit Protocol (Qiagen). 
Restriction endonucleases were purchased from Gibco BRL. T4 DNA ligase was 
purchased from Promega, and ELONGASE Enzyme Mix were purchased from 
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unless noted otherwise. Digested plasmids were separated by electrophoresis on 0.8% 
low melting agarose gels and extracted by the QIAquick Gel Extraction Kit Protocol 
(Qiagen). Competent E. coli cells were made and transformed (Heat-Shock) by the 
method of Inoue et aI., 1990. Standard techniques were used for electrophoresis and 
molecular cloning. 
Crossover peR: 
The protocol for the PCR was taken from ref. [25]. The primers used are listed in table 4. 
Platinum pfx DNA polymerase (Invitrogen) was used. The PCR cycles were as follows: 
denature: 94°C for 15 seconds, almeal: 55°C for 30 s, extend: 68°C for 1 min per Kb. IX 
of the supplied enhancer was used in the reaction mixture. 
Preparation of competent Brucella cells 
Wild type Brucella cells (2308) were grown in 5ml YENB (Yeast Extract and 
Nutrient Broth) media for 33 h at 37°C with shaking. Then 2.5 ml of the overnight 
culture was added to 50 ml of fresh YENB medium and was placed in a 37°C shaker until 
the Klett reading was between 70-80. The cells were harvested by chilling tbe flask on ice 
for 5 min and spinning the cells at 4000 x g for 10 min at 4°C. The medium was 
removed and discarded, and the pellet was washed twice by resuspending in 5 ml of cold 
water and centrifuging at 4000 x g for 10 min at 4°C. The supernatant was again 
removed and discarded. The pellet was resuspended in 1 ml of cold 10% glycerol and 
centrifuged, and the supernatant removed and discarded as before. The ceHs were 
resuspended to a final volume 200-300 JlI of cold 10% glycerol (Sharma and Schimke, 
1996). 
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Electroporation of suicide plasmids into B. abortlls 
50 1-11 of competent Brucella cells were placed in a microfuge tube and 1.5-2.1 f.!g 
of DNA was added. This was mixed and placed on ice for 1 min. The cells and DNA 
were transferred to a 0.1 cm electroporation cuvette. The cuvette was put in its holder and 
was attached to the power unit. Tbe voltage was set to 1250 V and the resis~ance to 200 
Q, and then it was pulsed. The cuvette was immediately removed and the cells washed 
out with 1 mJ SOC-B and placed in a sterile microfuge tube. The microfuge tubes were 
open and incubated at 37°C, 5% CO2 for 5 minutes, then closed and incubated for another 
one hour. Then the cells were sedimented for 5 min in a Millipore microfuge. The 
supernatant was discarded in a disinfectant. The pellet was resuspended in 0.2 ml SOC-B 
and plated on 2 SOC-B plates (0. Iml each) with no antibiotic. The plates were incubated 
overnight at 37°C, 5% CO2. The next day the growth was removed and resuspended in 
0.2 ml tryptose. Cells were spread on 2-4 tryptose plates with selective antibiotics and 
incubated at 37°C, 5% CO2 for 7-10 days (Lai et aI., 1990). 
Killing B. abortus Cells with Methanol 
Before B. abortus cells can be removed from the BL3 lab for DNA extraction, the 
cells must be killed. First the cells were grown in 3 rol of tryptose broth overnight at 
37°C. Next the cells are transferred to a sterile microfuge tube and are centrifuged for 5 
min, the supernatant was removed and discarded into a disinfectant. The pellet was 
resuspended in 0.1-0.2 ml tryptose broth, and 1-2 ml of methanol was added. This was 
incubated at room temperature for 5 min and then the cells were centrifuged for 5 min, 
the supernatant was removed and decontaminated. Again, the cells were resuspended in 
22 
0.1-0.2 ml tryptose broth and 1-2 ml of methanol was added. Then the cells were again 
incubated at room temperature for 5 min and were centrifuged for 5 min, and the 
supernatant was removed and decontaminated. The cells were resuspended in 0.1-0.2 ml 
tryptose broth and the viability of killed cells was checked by spreading 10 ilion tryptose 
plates and growing for 2 days at 3rC, 5% CO2. 
Genomic DNA Extraction of B. abortus 
Once the cells were killed (no growth on the tryptose plates after the second day) 
tbe genomic DNA from B. abortus was extracted as described except that the proteinase 
K digestion was carried out overnight at 37° instead of I hI (Wilson, 1994). 
Southern blot 
A Southern Blot was performed on the genomic DNA of B. abortus to detennine 
if the samples actually had the araD or aroBE genes present and to detect if the sacB-
kanamycin cassette was also present. The transfer of DNA to the membrane was 
followed as described in the S&S TurboBlotter and Blotting Assembly for Alkaline and 
Neutral Transfer. The probe was labeled with photobiotin (Forester et al., 1985) and 
detected by the Southem-Light & Southern-Star Chemiluminescent Detection System 
(Tropix). 
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Table 1 
Bacterial strains used in the study 
. .. . .... ~ ... . -~.	 ~ 
Strain Genotype 
B.abortus 2308 Wild type 
E.coli XLI-Blue recAl, endAI, gyrA96, thi-l, hsdR17!> 
supE44. relA 1 , lac 
E. coli strain RE 729 Tsx-356, supE42, h-, aroD352, RYrA. 
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Table 2 
'. Plasmids used in the -study' .." , . .... .... 
Plasmid Description 
PRE523 Brucella aroD 
pRE525 Brucella aroBE 
pRE167 AIO Brucella aroA 
pRE!7! Brucella pgi 
pUM24 Kan-sac cassette 
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Table 3 
Media used in the study 
Medium Contents 
LM Tryptone, yeast extract, NaCl, 
MgS04.7H2O 
5xA K2HP04, KHZP04, (NH4)2S04, 
Na3Cltrate.2HzO 
E.coli minimal medium 5xA, glucose, MgS04.7HzO 
Brucella SOC Tryptic soy broth, NaCl, MgClz, 
MgS04.7HzO, glucose 
5x Brucella NaCl, K2HP04, sodium thiosulfate, 
(NH4)2S04 
500x Brucella Vitamin B 1, nicotinic acid, 
Pantothenic acid, biotin. 
Brucell minimal medi urn. 5x, 500x, Erythritol, MgS04.7I-IzO 
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Table 4. Primers used in crossover PCR. Bases written in lower case are the 
tail and the ones wi th the upper case match sequences in the target genes. 
Prin1er Sequence 
AroA Co cgcacgcatgtcgacGCATGGGCGGAAAGCAC 
AroA Ci gttctgcagcggccgcgaattccgCTCGAAGCTGAAAGGCGTTGT 
AroANo aaaaactgcagGAAATGCCGGACAAGTGGTTA 
AIoA Ni cggaattcgcggccgctgcagaacGCCCGTAAGTGCCTGCGAATG 
GluP Co cgcacgcatgtcgacGCGCACACAGACCTCCTCI 
GluP Ci gttctgcagcggccgcgaattccgGTACATTATGCCCGTCAACCA 
GluP No aaaaactgcagGAAGCGGGAAAGCACGGTTGA 
• GluP Ni cggaattcgcggccgctgcagaacGCCCAGTCCGAAGCCCTGAT 
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Chapter IV 
Results 
I-Mutating the doned BrncelJa aroD by inserting Kan-Sac cassette: 
Plasmid pRE523 which contains the aroD gene, contains also another gene which 
encodes acetyl eoA carboxylase subunit. The two genes overlap with each other. Cia! 
cuts in two sites in the plasmid pRE523, one of them in the aroD gene (fig4). pRE523 
was partially digested with Clal. The ends were blunted, and were ligated to a blunt 
ended Kan-Sac cassette. The ligation mixture was electroporated to E.coli and the 
bacteria were cu~tured on kanamycin LM. The plasmid DNA was extracted from 
bacterial colonies by Qiagen protocol. In order to choose the desired plasmid (which has 
the kan-sac cassette only in the araD gene), a digestion with EcoRVwas carried out, and 
the DNA fragments were anal.yzed (fig 5). If Cial cuts only once and in the araD gene, 
the EcoRV restriction pattern should show a piece of about 300 bp, and another one of 
about 2800 (Table 5). Only one colony showed this pattern. (Lane 10 in fig 5). The 
plasmid was then electroporated into E.coli strain RE729 which is a tulroD, and the cells 
were cultured on a minimal media with and without aromatic amino acids. The bacteria 
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acids but could grow on aromatic amino acids containing minimal media, suggesting that 
the araD gene was mutated. The wild type plasmid pRE523 was used as a control (it 
could complement E.coli RE729). Table 5 shows the different possible EcoRV predicted 
restriction fragments of different clones that might result from kim-sac insertion in 
different Clal sites. The orientation of the kan-sac cassette was also considered. There are 
four positions of kan-sac insertion that can produce fragments of about 2.77 Kb and 0.33 
Kb with EcoRV digestion (listed in Table 5). Among those clones, only the one that got 
the insertion in the 836 position (araD) win fail to complement the E.coli RE729 strain. 
Further characterization was made using Pst! (fig.6). Kan-sac cassette has two Pst] sites, 
one at each end. The distance from Pstl site in the multiple cloning site (MCS) to the Pst! 
site at either end of the kan-sac cassette can lo.cate the cassette insertion regardless of its 
orientation. If the cassette was inserted in coding region of aroD (Clal site 836), a band 
of about 800 bp should appear. Rather, a band of about 1300 bp was obtained indicating 
that the insertion site was actually outside the coding region of aroD (at Clal site 401) 
contradicting the combined EcoR V and complementation results. 
2-Construction of aroA, and pg; deletion mutants by crossover peR: 
The deletion by crossover peR is a two-step pTOcess and involves the use of four primers 
(fig. 7). The tails attached to the primers No, and Co carry Pst! and SalI sites respectively. 
The tails of the primers Ni and Ci are complementary to each other in a way that allows 
them to anneal to each other, and they carry a NotI site. In the first step, a peR for both N 
terminal and C temlinal of the gene are carried out separately using the No-Ni, and Co-Ci 
primer pairs respectively. 
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Table.5. The EcoRV predicted restriction patterns for different aroD and kan-sac clones. 
The kan-sac cassette was inserted into plasmid pRE523 after partial digestion with Cial. 
The Cia! cuts twice in the aroD: once in 401 and the other is in 836 (within the aroD 
coding region figA). Cial also cuts in the multiple cloning site of the plasmid (PSK). The 
aroD is oriented in a way that makes the beginning of the gene close to the T7 promotor. 
The orientation of the kan-sac cassette is expressed by (+) if the beginning of the cassette 
was from the T3 side and by (-) if the insertion was in the opposite direction. EcoRV has 
three sites in aroD: 457, 789, 1225, one site in the Kan-sac: 2723, and one site in the 
MCS (between the Cia! site and the aroD gene). 
Position ofKan-Sac 
836 
836 
401 
401 
Cia/in MCS 
elaIin MCS 
401-836 fragment 
removed 
401-836 fragment 
removed 
From MCS- 401 
removed 
From MCS- 401 
removed 
From MCS- 836 
removed 
From MCS- 836 
removed 
Orientation of Kan- Fragments in bp 
sac 
+ 470, 332, 150, 3112, 
3383 
-
470,332,2770,490, 
3382 
+ 501, 2779, 332, 436, 
3382 
-
3124,150,332,436, 
3382 
+ 2723,457,332,436, 
3483 
-
101,457,332,436, 
6105 
+ 502,3112,3382 
-
3124, 490, 3382 
+ 2779,332,436,3483 
-
150, 332, 436, 6105 
+ 3312,3483 
-
490,6105 
Table 5 
Predicted ability to 
complement E. coli 
RE729 
-
-
+ 
+ 
+ 
+ 
-
-
+ 
+ 
-
-
31 
Fig.5. EcoRV restriction patterns for different aroD and Kan-sac clones. 
The DNA ladder is lKb plus ladder. 
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Fig.6. The PstJ restriction pattern for the selected aroD clone. 
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The gel in fig. 8 shows the bands which correspond to the aroA N telminal (left lane), 
and the pgi N terminal (right lane). The gel in fig.9 shows the bands that correspond to 
the C parts of aroA (the last three right lane), and pgi (the first two left lanes). In this 
round of PCR bands of the expected sizes were obtained. In the second round of PCR, I 
I-ll of both the previous PCR mixtures was used as a template, and the primer pair Co-No 
was used. Fig. 7 shows that the DNA synthesis starts from the complementary tails and 
proceeds to give the full fragment (N tenninal plus C terminal with the deletion). From 
that point, the primer pair Co-No will amplify this fragment (N terminal plus C terminal). 
Fig. 10 shows the pgi second step PCR. I obtained the bands of the expected size (2.5 Kb) 
plus a band of about 1 Kb. Changing the reaction conditions did not remove the 
interfering band. Fig.II shows the aroA second step PCR and the bands are of the 
expected size (about 1000 bp). The PCR products were then cloned into the PCR vector 
pCR2.1 TOPO of the TA cloning kit (Invitrogen). Ligation mixtures were transferred into 
the provided cells and the plasmid DNA was extracted. Plasmids were analyzed using the 
restriction enzymes ApaI and SacI and they were found to contain the PCR products. 
3- Electroporation of mutated genes aroBE and aroD into B. abortus 2308: 
aroBE was cloned and mutated by insertion of kan-sac cassette within the coding 
sequence (work done before in the lab). Kan-sac cassette contains the kanamycin 
resistance gene and the Bacillus subtilis sacB gene. The sacB gene encodes levansucrase, 
an enzyme involved in levan synthesis and sucrose hydrolysis [26}. Production of 
levansucrase in many gram-negative bacteria was found to be lethal in the presence of 
5% sucrose. 
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Homologous recombination was used in an attempt to replace the endogenous 
chromosomal copy of the aroD, and aroBE genes with an inactivated copy of these 
genes. The plasmid pRE525 that carries the mutated genes aroBE was e1ectropoTated into 
Brucella and wild type strain was use as a control. The cells were plated on tryptose agar 
for one day and then were plated on selective plates with kanamycin for 4-7 days. The 
colonies were then tested for the double crossover by plating on sucrose-kanamycin 
plates, kanamycin plates, and ampicillin plates (all tryptose plates). The cells that had a 
double crossover should not grow on plates with ampicillin or on plates with sucrose hut 
should grow on plates with kanamycin only. Almost aU the cells did not grow on 
ampicillin plates. Two colonies from each plate were not ahle to grow with sucrose. 
These colonies were picked and plated on a minimal medium with and without aromatic 
amino acids. All the colonies were able to grow on minimal medium lacking the aromatic 
amino acids mix. It is worthy to note that these colonies were able to grow on sucrose 
plates when re-plated. The genomic DNA was extracted from these colonies after killing 
them with methanol. The genomic DNA was digested by EcoRV and was hybridized 
against plasmid pMU24 that contains the kan-sac cassette. No bands were detected from 
the mutated bacteria. 
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Fig.8. The crossover peR for the N terminal of the aroA gene (left lane), and 
pgi gene (right lane). The bands are of the expected sizes. The DNA ladder 
is 1kb plus ladder 
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Fig.9. The crossover peR for the C terminal of the aroA gene (the three 
lanes to the right of the ladder), and the pgi gene (the two lanes to the left of 
the ladder). The bands are of the expected sizes. The DNA ladder is lkb plus 
ladder 
JOOO 
~SO 
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B50 
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Fig.9. 
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Fig.lO. The second step of the crossover peR for the pgi gene. The size of 
the bands should be around 2500 bp. Smaller bands can be also seen. The 
DNA ladder is lkb plus ladder. 
FIg.tO. 
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Fig 11. The second step in the crossover peR for the aroA gene. The bands were of the 
expected sizes. The DNA ladder is lkb plus ladder. 
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Chapter V 
Discussion 
Knocking out the aromatic amino acid pathway attenuated many intracellular bacteria] 
pathogens such as Salmonella typhimirium and Yersinia. In addition to that, Hong et a] 
reported that a B.abortus mutant that couldn't establish an infection was auxotrophic for 
aromatic amino acids [20]. These findings suggest that the aromatic amino acid pathway 
is crucial for the survival of the intracellular bacteria inside the host cells. This 
ilTIportance may come from the fact that the aro pathway supplies the bacteria with 
nutrients that are not available in the animal eukaryotic host cells. These nutrients include 
phenylalanine, tryptophan, para-aminobenzoic acid, and folic acid. Mutant bacteria are 
constructed by homologous recombination, which replaces the genome copy of the target 
gene by another mutated copy carried on a suicide vector that cannot replicate in the 
target cells. Two markers are at least required for the detection of the double crossover 
bacteria. In the case of aroD, and aroBE genes, a kan-sClc cassette was inserted in the 
Coding region of these genes and an ampicillin resistance gene was camed on the 
'Plasmid. That will allow the detection of the double crossover (loss of both the wild type 
genome copy of the gene and the plasmid) by one step. The ability of the ceUs to grow on 
tuinimal media even though they could grow on kanamycin is puzzling since B.abortus 
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j\Dother thing that might be tried is to transfer the plasmid via bacterial mating. To do 
t11is, a nalidixic acid Brucella strain should be used, and the genes should be cloned in 
pSK out plasmid, a vector that has the mobilizing and transferring genes [27]. Using this 
rJ1ethod may help since mating is actually quite a bit more efficient than electroporation. 
since the aroD gene overlaps with acetyl CoA carboxylase subunit, it would be important 
to try to mutate aroD without affecting the translation of the acetyl CoA carboxylase 
subunit (polar effect). The same problem was faced before with aroA gene, which 
overlaps with CMP kinase. Mutants in which both aroA and CMP kinase are interrupted 
were not viable. To avoid this I tried to make a deletion of aroA by inverse peR. In 
inverse PCR mutagenesis, primers are designed so that they go out of the deleted region. 
The deleted region should be divisible by 3 to avoid the polar effect. Then the peR 
products were cloned into a pBluescript vector. The PCR product was then sequenced 
using T3 and T7 primers. Unfortunately, the sequence obtained did not match the 
expected sequence. Then the aroA gene was deleted by crossover peR. Like the inverse 
peR, the primers were designed in a way that de.letes a region that is divisible by 3. The 
future research on this topic may figure out ways to obtain the required Brucella mutants 
and to study the viability of these mutants inside a macrophage cell culture or a live 
animal model. 
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